In mice with rheumatoid arthritis, some animals treated with a specific nanoparticle never developed joint swelling for 10 months, indicating the treatment might lead to long-lasting immune tolerance.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether this nanoparticle platform consistently induces long-term (≥200 days) arthritis-free survival across multiple independent studies in K/BxN or similar models.
A systematic review and meta-analysis of all published studies using GPI-targeted nanoparticles in K/BxN mice, pooling the proportion of mice remaining arthritis-free at 200+ days, with assessment of heterogeneity and publication bias.
Whether the nanoparticle causes a higher proportion of mice to remain arthritis-free beyond 200 days compared to controls.
A double-blind, randomized controlled trial in 100 K/BxN mice, randomized to nanoparticle or control, with arthritis scored daily for 300 days, primary outcome: proportion of mice arthritis-free at day 300, analyzed by Kaplan-Meier survival analysis.
Whether nanoparticle exposure predicts time to arthritis onset over a 300-day period in a defined mouse cohort.
A prospective cohort study of 150 K/BxN mice receiving the nanoparticle at disease onset, tracking arthritis development daily for 300 days, with time-to-event analysis adjusted for baseline immune status.
Whether mice remaining arthritis-free beyond 300 days are more likely to have received the nanoparticle than those developing early disease.
A case-control study comparing 40 mice arthritis-free at 300 days (cases) with 40 that developed arthritis by day 60 (controls), retrospectively assessing nanoparticle exposure and treatment timing.
Whether mice assessed at day 300 have lower arthritis scores if they received the nanoparticle compared to those who did not.
A cross-sectional comparison of arthritis scores in 50 nanoparticle-treated and 50 untreated K/BxN mice at day 300 post-induction.